Given that the non-glycosylated form of irisin inhibits the proinflammatory activity of adipocytes [6] and macrophages [7,8,9], we verified whether its glycosylation changes the nature of its impact on the equivalent of obesity-related meta-inflammation. The gene discussed is FNDC5; the disease is Obesity.